Literature DB >> 20713461

Vascularization predicts overall survival and risk of transformation in follicular lymphoma.

Pedro Farinha1, Alastair H Kyle, Andrew I Minchinton, Joseph M Connors, Aly Karsan, Randy D Gascoyne.   

Abstract

Follicular lymphoma patients display heterogeneous overall survival and variable risk of transformation. Recent studies have highlighted the role of the microenvironment. The contribution of microvessel density to follicular lymphoma survival remains controversial. We used a quantitative tumor mapping approach to determine whether the degree of vascularization correlated with outcome in a uniformly treated cohort. Whole-tissue sections of diagnostic biopsies from 84 cases were stained for CD34 and tumor-to-vessel-distance that encompassed 90% of the tumor (TVD(90)) was determined using image analysis. Twenty-one cases with lower TVD(90) showed inferior overall survival (P=0.0001) and high risk of transformation (P=0.01). These cases significantly correlated with increased Lymphoma-Associated Macrophages (χ(2)=0.025). In multivariate analysis macrophages content, IPI and TVD(90) were independent predictors of overall survival (P=0.05, P=0.001 and P=0.01, respectively) and IPI and TVD(90) predicted risk of transformation (P=0.008 and P=0.08, respectively). Increased angiogenesis is an independent marker of inferior survival and may promote transformation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713461      PMCID: PMC2995576          DOI: 10.3324/haematol.2009.021766

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  21 in total

1.  Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma.

Authors:  S Monestiroli; P Mancuso; A Burlini; G Pruneri; C Dell'Agnola; A Gobbi; G Martinelli; F Bertolini
Journal:  Cancer Res       Date:  2001-06-01       Impact factor: 12.701

Review 2.  The history of the angiogenic switch concept.

Authors:  D Ribatti; B Nico; E Crivellato; A M Roccaro; A Vacca
Journal:  Leukemia       Date:  2006-09-21       Impact factor: 11.528

3.  Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

Authors:  Pedro Farinha; Hamid Masoudi; Brian F Skinnider; Karey Shumansky; John J Spinelli; Karamjit Gill; Richard Klasa; Nicolas Voss; Joseph M Connors; Randy D Gascoyne
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

Review 4.  Bone marrow angiogenesis in multiple myeloma.

Authors:  A Vacca; D Ribatti
Journal:  Leukemia       Date:  2006-02       Impact factor: 11.528

5.  Increased vascularization predicts favorable outcome in follicular lymphoma.

Authors:  Ad Koster; Joannes H J M van Krieken; Marius A Mackenzie; Margit Schraders; George F Borm; Jeroen A W M van der Laak; William Leenders; Konnie Hebeda; John M M Raemaekers
Journal:  Clin Cancer Res       Date:  2005-01-01       Impact factor: 12.531

6.  Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.

Authors:  R K Singh; M Gutman; C D Bucana; R Sanchez; N Llansa; I J Fidler
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

7.  Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules.

Authors:  Benjamin J Moeller; Yiting Cao; Chuan Y Li; Mark W Dewhirst
Journal:  Cancer Cell       Date:  2004-05       Impact factor: 31.743

Review 8.  Role of angiogenesis in tumor growth and metastasis.

Authors:  Judah Folkman
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

9.  Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression.

Authors:  S Montoto; A López-Guillermo; A Altés; G Perea; A Ferrer; M Camós; L Villela; F Bosch; J Esteve; F Cervantes; J Bladé; B Nomdedeu; E Campo; J Sierra; E Montserrat
Journal:  Ann Oncol       Date:  2004-10       Impact factor: 32.976

10.  Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma.

Authors:  Burhan Hazar; Semra Paydas; Suzan Zorludemir; Berksoy Sahin; Ilhan Tuncer
Journal:  Leuk Lymphoma       Date:  2003-12
View more
  13 in total

1.  [Ultrasound in the diagnostic management of malignant lymphomas].

Authors:  H-P Weskott
Journal:  Radiologe       Date:  2012-04       Impact factor: 0.635

Review 2.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

Review 3.  Pathogenesis of follicular lymphoma.

Authors:  Robert Kridel; Laurie H Sehn; Randy D Gascoyne
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

4.  High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy.

Authors:  Teresa M Cardesa-Salzmann; Luis Colomo; Gonzalo Gutierrez; Wing C Chan; Dennis Weisenburger; Fina Climent; Eva González-Barca; Santiago Mercadal; Leonor Arenillas; Sergio Serrano; Ray Tubbs; Jan Delabie; Randy D Gascoyne; Joseph M Connors; Jose L Mate; Lisa Rimsza; Rita Braziel; Andreas Rosenwald; Georg Lenz; George Wright; Elaine S Jaffe; Louis Staudt; Pedro Jares; Armando López-Guillermo; Elias Campo
Journal:  Haematologica       Date:  2011-05-05       Impact factor: 9.941

5.  The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium.

Authors:  Birgitta Sander; Daphne de Jong; Andreas Rosenwald; Wanling Xie; Olga Balagué; Maria Calaminici; Joaquim Carreras; Philippe Gaulard; John Gribben; Anton Hagenbeek; Marie José Kersten; Thierry Jo Molina; Abigail Lee; Santiago Montes-Moreno; German Ott; John Raemaekers; Gilles Salles; Laurie Sehn; Christoph Thorns; Björn E Wahlin; Randy D Gascoyne; Edie Weller
Journal:  Haematologica       Date:  2014-02-07       Impact factor: 9.941

6.  Intracellular and Extracellular miRNAs in Regulation of Angiogenesis Signaling.

Authors:  Nnenna A Finn; Charles D Searles
Journal:  Curr Angiogenes       Date:  2012-12

7.  PI3Kδ inhibition reshapes follicular lymphoma-immune microenvironment cross talk and unleashes the activity of venetoclax.

Authors:  Neus Serrat; Martina Guerrero-Hernández; Alba Matas-Céspedes; Anella Yahiaoui; Juan G Valero; Ferran Nadeu; Guillem Clot; Miriam Di Re; Marc Corbera-Bellalta; Laura Magnano; Alfredo Rivas-Delgado; Anna Enjuanes; Silvia Beà; Maria C Cid; Elías Campo; Joan Montero; Daniel J Hodson; Armando López-Guillermo; Dolors Colomer; Stacey Tannheimer; Patricia Pérez-Galán
Journal:  Blood Adv       Date:  2020-09-08

8.  The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growth.

Authors:  Donald T Yapp; May Q Wong; Alastair H Kyle; Shannon M Valdez; Jenny Tso; Andrew Yung; Piotr Kozlowski; David A Owen; Andrzej K Buczkowski; Stephen W Chung; Charles H Scudamore; Andrew I Minchinton; Sylvia S W Ng
Journal:  Angiogenesis       Date:  2016-03-09       Impact factor: 9.596

9.  The clinical impact of mean vessel size and solidity in breast carcinoma patients.

Authors:  Lars Tore Gyland Mikalsen; Hari Prasad Dhakal; Øyvind S Bruland; Bjørn Naume; Elin Borgen; Jahn M Nesland; Dag Rune Olsen
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

10.  Association of VEGFA-2578 C>A polymorphism with clinicopathological aspects and outcome in follicular lymphoma patients.

Authors:  G R A de Mendonça; A B C Brito; R M Rocha; M T Delamain; R de Andrade Natal; F A Soares; G W B Colleoni; C A Souza; J Vassallo; C S P Lima
Journal:  Blood Cancer J       Date:  2016-08-26       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.